BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31686009)

  • 1. A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain.
    Ramírez-García PD; Retamal JS; Shenoy P; Imlach W; Sykes M; Truong N; Constandil L; Pelissier T; Nowell CJ; Khor SY; Layani LM; Lumb C; Poole DP; Lieu T; Stewart GD; Mai QN; Jensen DD; Latorre R; Scheff NN; Schmidt BL; Quinn JF; Whittaker MR; Veldhuis NA; Davis TP; Bunnett NW
    Nat Nanotechnol; 2019 Dec; 14(12):1150-1159. PubMed ID: 31686009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained endosomal release of a neurokinin-1 receptor antagonist from nanostars provides long-lasting relief of chronic pain.
    Latorre R; Ramírez-Garcia PD; Hegron A; Grace JL; Retamal JS; Shenoy P; Tran M; Aurelio L; Flynn B; Poole DP; Klein-Cloud R; Jensen DD; Davis TP; Schmidt BL; Quinn JF; Whittaker MR; Veldhuis NA; Bunnett NW
    Biomaterials; 2022 Jun; 285():121536. PubMed ID: 35533442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief.
    Jensen DD; Lieu T; Halls ML; Veldhuis NA; Imlach WL; Mai QN; Poole DP; Quach T; Aurelio L; Conner J; Herenbrink CK; Barlow N; Simpson JS; Scanlon MJ; Graham B; McCluskey A; Robinson PJ; Escriou V; Nassini R; Materazzi S; Geppetti P; Hicks GA; Christie MJ; Porter CJH; Canals M; Bunnett NW
    Sci Transl Med; 2017 May; 9(392):. PubMed ID: 28566424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain relief.
    Hegron A; Peach CJ; Tonello R; Seemann P; Teng S; Latorre R; Huebner H; Weikert D; Rientjes J; Veldhuis NA; Poole DP; Jensen DD; Thomsen ARB; Schmidt BL; Imlach WL; Gmeiner P; Bunnett NW
    Proc Natl Acad Sci U S A; 2023 May; 120(22):e2220979120. PubMed ID: 37216510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A lipid-anchored neurokinin 1 receptor antagonist prolongs pain relief by a three-pronged mechanism of action targeting the receptor at the plasma membrane and in endosomes.
    Mai QN; Shenoy P; Quach T; Retamal JS; Gondin AB; Yeatman HR; Aurelio L; Conner JW; Poole DP; Canals M; Nowell CJ; Graham B; Davis TP; Briddon SJ; Hill SJ; Porter CJH; Bunnett NW; Halls ML; Veldhuis NA
    J Biol Chem; 2021; 296():100345. PubMed ID: 33515548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurokinin 1 receptor activation in the rat spinal cord maintains latent sensitization, a model of inflammatory and neuropathic chronic pain.
    Chen W; Marvizon JC
    Neuropharmacology; 2020 Oct; 177():108253. PubMed ID: 32736088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurokinin Receptor 1 (NK1R) Antagonist Aprepitant Enhances Hematoma Clearance by Regulating Microglial Polarization via PKC/p38MAPK/NFκB Pathway After Experimental Intracerebral Hemorrhage in Mice.
    Jin P; Deng S; Sherchan P; Cui Y; Huang L; Li G; Lian L; Xie S; Lenahan C; Travis ZD; Zhang JH; Gong Y; Tang J
    Neurotherapeutics; 2021 Jul; 18(3):1922-1938. PubMed ID: 34244927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
    Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
    J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-converting enzyme-1 regulates trafficking and signalling of the neurokinin 1 receptor in endosomes of myenteric neurones.
    Pelayo JC; Poole DP; Steinhoff M; Cottrell GS; Bunnett NW
    J Physiol; 2011 Nov; 589(Pt 21):5213-30. PubMed ID: 21878523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recycling and resensitization of the neurokinin 1 receptor. Influence of agonist concentration and Rab GTPases.
    Roosterman D; Cottrell GS; Schmidlin F; Steinhoff M; Bunnett NW
    J Biol Chem; 2004 Jul; 279(29):30670-9. PubMed ID: 15128739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation-induced abnormalities in the subcellular localization and trafficking of the neurokinin 1 receptor in the enteric nervous system.
    Poole DP; Lieu T; Pelayo JC; Eriksson EM; Veldhuis NA; Bunnett NW
    Am J Physiol Gastrointest Liver Physiol; 2015 Aug; 309(4):G248-59. PubMed ID: 26138465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamin and Rab5a-dependent trafficking and signaling of the neurokinin 1 receptor.
    Schmidlin F; Dery O; DeFea KO; Slice L; Patierno S; Sternini C; Grady EF; Bunnett NW
    J Biol Chem; 2001 Jul; 276(27):25427-37. PubMed ID: 11306580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Substance P and Its Receptor Neurokinin 1 in Chronic Prurigo: A Randomized, Proof-of-Concept, Controlled Trial with Topical Aprepitant.
    Ohanyan T; Schoepke N; Eirefelt S; Hoey G; Koopmann W; Hawro T; Maurer M; Metz M
    Acta Derm Venereol; 2018 Jan; 98(1):26-31. PubMed ID: 28853492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute colitis induces neurokinin 1 receptor internalization in the rat lumbosacral spinal cord.
    Zhang MM; Ji W; Pei LY; Wang W; Chen T; Wang W; Li H; Zhang T; Wu SX; Li YQ
    PLoS One; 2013; 8(3):e59234. PubMed ID: 23555638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission.
    Yarwood RE; Imlach WL; Lieu T; Veldhuis NA; Jensen DD; Klein Herenbrink C; Aurelio L; Cai Z; Christie MJ; Poole DP; Porter CJH; McLean P; Hicks GA; Geppetti P; Halls ML; Canals M; Bunnett NW
    Proc Natl Acad Sci U S A; 2017 Nov; 114(46):12309-12314. PubMed ID: 29087309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance P and the Neurokinin-1 Receptor: The New CRF.
    Schank JR; Heilig M
    Int Rev Neurobiol; 2017; 136():151-175. PubMed ID: 29056150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-converting enzyme 1 and β-arrestins exert spatiotemporal control of substance P-induced inflammatory signals.
    Jensen DD; Halls ML; Murphy JE; Canals M; Cattaruzza F; Poole DP; Lieu T; Koon HW; Pothoulakis C; Bunnett NW
    J Biol Chem; 2014 Jul; 289(29):20283-94. PubMed ID: 24898255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential in vitro therapeutic effects of targeting SP/NK1R system in cervical cancer.
    Mozafari M; Ebrahimi S; Darban RA; Hashemy SI
    Mol Biol Rep; 2022 Feb; 49(2):1067-1076. PubMed ID: 34766230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of neurokinin-1 receptor antagonists in MG-63 human osteosarcoma xenografts.
    Muñoz M; Berger M; Rosso M; Gonzalez-Ortega A; Carranza A; Coveñas R
    Int J Oncol; 2014 Jan; 44(1):137-46. PubMed ID: 24190675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-course of the internalization and recycling of neurokinin 1 receptors in rat dorsal horn neurons.
    Wang X; Marvizón JC
    Brain Res; 2002 Jul; 944(1-2):239-47. PubMed ID: 12106686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.